Acarbose is an oral alpha-glucosidase inhibitor for use in the management of noninsulin dependent diabetes mellitus. We tried to detemined to efficacy of Acrabose monotherapy on glycemic control in patients with nonisulin dependent diabetes mellitus w...
Acarbose is an oral alpha-glucosidase inhibitor for use in the management of noninsulin dependent diabetes mellitus. We tried to detemined to efficacy of Acrabose monotherapy on glycemic control in patients with nonisulin dependent diabetes mellitus who were not adequately controlled with diet and exercise. Thirty four patients with noninsulin dependent diabetes mellitus who showed unacceptable range of glycemic control were treated with oral Acarbose. Acarbose reduced the level of mean fasting blood glucose, postprandial blood glucose after 4 and 8 weeks of the trial. The lipids, triglyceride and cholesterol level were significantly reduced by along with Acarbose treatment.
Acarbose, through its unique mechanism of action, appears to bo a safe and effective adjuvant agent to diet and exercise therapy for treatment of noninsulin dependent diabetes mellitus.